Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
about
Pruritus in female patientsRecurrent vulvovaginal candidiasis.Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists aGenital mycotic infections in patients with diabetes.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.The recurrent vulvovaginal candidiasis: proposal of a personalized therapeutic protocolMycology - an update Part 3: Dermatomycoses: topical and systemic therapy.Diagnostic Value of Vaginal Discharge, Wet Mount and Vaginal pH - An Update on the Basics of Gynecologic InfectiologyPractices of Lebanese gynecologists regarding treatment of recurrent vulvovaginal candidiasisRecurrent vulvovaginal candidiasis: A review of guideline recommendations.Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013)Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USAFactors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis.Chronic vulvovaginal candidiasis: what we know and what we have yet to learn.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Non-response to fluconazole maintenance treatment (ReCiDiF regimen) for recurrent vulvovaginal candidosis is not related to impaired glucose metabolism.Candida vulvovaginitis: A store with a buttery and a show window.Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).Management of chronic vulvovaginal candidiasis: a long term retrospective study.Comparison of two long-term gestagen regimens in the management of recurrent vulvovaginal candidiasis: A pilot study.Recurrent vulvovaginal candidosis: focus on the vulva.Quality of life in patients with chronic vulvovaginal candidiasis: A before and after study on the impact of oral fluconazole therapy.Use of Dermasilk briefs in recurrent vulvovaginal candidosis: safety and effectivenessIn vitro Assessment of Gentian Violet Anti-CandidaActivity
P2860
Q26828038-5CD0E969-453A-44CC-AAA9-BB24AC778584Q33798920-C243E709-B7B1-477B-804C-CFAD3485BBF7Q34269717-807A10F6-9685-4D7D-A01F-8DA5433ADAFAQ34349532-1CB194B4-9C89-4BF2-B408-B05925FDA24AQ34505582-44BE678F-0ACB-4745-8CD5-B18AFDDB2C01Q35157622-B345B554-BC51-472F-B738-5CCF38DB046FQ35616204-C7F2F813-1448-49DF-B58F-C6EE0A59C41FQ35624659-18407B13-3CD5-4BE7-B47A-EE0BD87AA940Q35731576-1C6FF0EB-954A-4D40-AE0C-90FAEC209138Q36309993-85DC7C39-CFD0-49BE-86FD-C7AB6DF7853FQ36743194-8D02D295-E7CD-4494-BB73-98C974E39642Q36850886-26D6DA86-AD72-448A-8200-1F7225DFA02DQ37274301-6EA5C8D6-3559-4E64-A6B5-61EAFC59117DQ37407646-D5EF28FC-EBE6-495C-9678-595E3DDB8610Q38045402-85EDE1DB-AF29-4B4B-89D2-2F36E63AA7EAQ38696236-8C383FA3-51DC-4681-8B2D-CD0B5A9FA551Q38827140-468CA318-97DA-4D48-BA36-B05A6D28B9D5Q38968429-BF7AA05C-8115-4C5F-AE5D-E0B42ABE9F1AQ39035805-469382A9-C5E5-4A24-8C5B-5E294A1FED18Q39718338-673D7CBC-C37C-4A0F-A940-15187E92C993Q40380065-A5A757B2-F129-4EAC-AA65-51F9F83D2561Q51458700-AA3CF33B-8092-434B-B414-DD67F4C21C60Q53794510-A64F8FA9-945C-4865-84FB-6EE41AA450D1Q56981845-C971AC1A-B770-41F5-ACE5-661893A35C69Q56988745-EF30989A-4D9D-4938-A100-F5441423A022
P2860
Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Individualized decreasing-dose ...... l candidiasis (ReCiDiF trial).
@en
Individualized decreasing-dose ...... rrent vulvovaginal candidiasis
@nl
type
label
Individualized decreasing-dose ...... l candidiasis (ReCiDiF trial).
@en
Individualized decreasing-dose ...... rrent vulvovaginal candidiasis
@nl
prefLabel
Individualized decreasing-dose ...... l candidiasis (ReCiDiF trial).
@en
Individualized decreasing-dose ...... rrent vulvovaginal candidiasis
@nl
P2093
P1476
Individualized decreasing-dose ...... l candidiasis (ReCiDiF trial).
@en
P2093
Annie Vereecken
Geert Byttebier
Gert Bellen
Johan Van Eldere
Luc Verguts
Michel Stalpaert
Piet Hinoul
Ronald Walckiers
P304
P356
10.1016/J.AJOG.2008.06.029
P407
P577
2008-10-30T00:00:00Z